BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9878554)

  • 1. Elongation of the N-acyl side chain of sialic acids in MDCK II cells inhibits influenza A virus infection.
    Keppler OT; Herrmann M; von der Lieth CW; Stehling P; Reutter W; Pawlita M
    Biochem Biophys Res Commun; 1998 Dec; 253(2):437-42. PubMed ID: 9878554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.
    Weis W; Brown JH; Cusack S; Paulson JC; Skehel JJ; Wiley DC
    Nature; 1988 Jun; 333(6172):426-31. PubMed ID: 3374584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface influenza haemagglutinin can mediate infection by other animal viruses.
    Fuller SD; von Bonsdorff CH; Simons K
    EMBO J; 1985 Oct; 4(10):2475-85. PubMed ID: 2996880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides.
    Matrosovich MN; Gambaryan AS; Tuzikov AB; Byramova NE; Mochalova LV; Golbraikh AA; Shenderovich MD; Finne J; Bovin NV
    Virology; 1993 Sep; 196(1):111-21. PubMed ID: 8356788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic sialic acid analog that is resistant to the receptor-destroying enzyme can be used by influenza C virus as a receptor determinant for infection of cells.
    Herrler G; Gross HJ; Brossmer R
    Biochem Biophys Res Commun; 1995 Nov; 216(3):821-7. PubMed ID: 7488199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells.
    Gambaryan AS; Karasin AI; Tuzikov AB; Chinarev AA; Pazynina GV; Bovin NV; Matrosovich MN; Olsen CW; Klimov AI
    Virus Res; 2005 Dec; 114(1-2):15-22. PubMed ID: 15996787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine).
    Gambaryan AS; Tuzikov AB; Piskarev VE; Yamnikova SS; Lvov DK; Robertson JS; Bovin NV; Matrosovich MN
    Virology; 1997 Jun; 232(2):345-50. PubMed ID: 9191848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
    Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
    Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of influenza virus infection by an N-thioacetylneuraminic acid acrylamide copolymer resistant to neuraminidase.
    Itoh M; Hetterich P; Isecke R; Brossmer R; Klenk HD
    Virology; 1995 Oct; 212(2):340-7. PubMed ID: 7571403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities.
    Stevens J; Blixt O; Glaser L; Taubenberger JK; Palese P; Paulson JC; Wilson IA
    J Mol Biol; 2006 Feb; 355(5):1143-55. PubMed ID: 16343533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.
    Govorkova EA; Matrosovich MN; Tuzikov AB; Bovin NV; Gerdil C; Fanget B; Webster RG
    Virology; 1999 Sep; 262(1):31-8. PubMed ID: 10489338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the biological phenotype of low-yielding (L) and high-yielding (H) variants of swine influenza virus A/NJ/11/76 are associated with their different receptor-binding activity.
    Gambaryan AS; Matrosovich MN; Bender CA; Kilbourne ED
    Virology; 1998 Aug; 247(2):223-31. PubMed ID: 9705915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles.
    Papp I; Sieben C; Ludwig K; Roskamp M; Böttcher C; Schlecht S; Herrmann A; Haag R
    Small; 2010 Dec; 6(24):2900-6. PubMed ID: 21104827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography.
    Sauter NK; Hanson JE; Glick GD; Brown JH; Crowther RL; Park SJ; Skehel JJ; Wiley DC
    Biochemistry; 1992 Oct; 31(40):9609-21. PubMed ID: 1327122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance.
    Mandenius CF; Wang R; Aldén A; Bergström G; Thébault S; Lutsch C; Ohlson S
    Anal Chim Acta; 2008 Aug; 623(1):66-75. PubMed ID: 18611459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor.
    Takemoto DK; Skehel JJ; Wiley DC
    Virology; 1996 Mar; 217(2):452-8. PubMed ID: 8610436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of sialic acid in cell receptors for vesicular stomatitis virus.
    Superti F; Girmenta C; Seganti L; Orsi N
    Acta Virol; 1986 Jan; 30(1):10-8. PubMed ID: 2871728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the selectin ligand sialyl-Lewis(x) by biochemical engineering of sialic acids.
    Horstkorte R; Rau K; Reutter W; Nöhring S; Lucka L
    Exp Cell Res; 2004 May; 295(2):549-54. PubMed ID: 15093751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical engineering of the acyl side chain of sialic acids stimulates integrin-dependent adhesion of HL60 cells to fibronectin.
    Villavicencio-Lorini P; Laabs S; Danker K; Reutter W; Horstkorte R
    J Mol Med (Berl); 2002 Oct; 80(10):671-7. PubMed ID: 12395152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.
    Hidari KI; Murata T; Yoshida K; Takahashi Y; Minamijima YH; Miwa Y; Adachi S; Ogata M; Usui T; Suzuki Y; Suzuki T
    Glycobiology; 2008 Oct; 18(10):779-88. PubMed ID: 18621993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.